Table 3.
N | Fact-B** | 95% CI | Fact-G | 95% CI | TOI-PFB | 95% CI | |
---|---|---|---|---|---|---|---|
Married* | |||||||
Yes | 1,846 | Ref | Ref | Ref | |||
No | 1,348 | −4.96 | (−6.41, −3.52) | −3.90 | (−5.04, −2.77) | −1.77 | (−2.85, −0.69) |
p-value | <0.001 | <0.001 | 0.001 | ||||
Close friends and relatives | |||||||
>15 | 812 | Ref | Ref | Ref | |||
10-15 | 1,120 | −2.46 | (−4.09, −0.83) | −1.75 | (−3.03, −0.47) | −1.26 | (−2.48, −0.03) |
6-9 | 664 | −6.20 | (−8.06, −4.34) | −4.94 | (−6.41, −3.48) | −3.32 | (−4.72, −1.92) |
0-5 | 598 | −10.54 | (−12.48, −8.60) | −8.86 | (−10.39, −7.34) | −5.29 | (−6.75, −3.83) |
p-value, continuous | <0.001 | <0.001 | <0.001 | ||||
Any church participation | |||||||
Yes | 2,230 | Ref | Ref | Ref | |||
No | 964 | −1.78 | (−3.20, −0.37) | −1.42 | (−2.54, −0.30) | −0.90 | (−1.96, 0.15) |
p-value | 0.01 | 0.01 | 0.09 | ||||
Any volunteering | |||||||
Yes | 825 | Ref | Ref | Ref | |||
No | 2,369 | −1.90 | (−3.39, −0.42) | −1.43 | (−2.60, −0.26) | −1.29 | (−2.40, −0.19) |
p-value | 0.01 | 0.02 | 0.02 |
Multivariate-adjusted models adjusted for age (continuous), race/ethnicity (White (ref), African-American, Hispanic, Asian, other), education (<HS, HS, <college, college degree or greater), income (<$25K, $25-<$70K, $70K+(ref)), stage (I (ref), II, III, IV), estrogen receptor status (positive, negative (ref)), nodal status (positive, negative (ref)), surgery type (mastectomy (ref), lumpectomy, other), chemotherapy (yes, no (ref)), hormonal treatment (yes, no (ref)), radiation (yes, no (ref)), menopausal status (postmenopausal, premenopausal (ref)), parity (0, 1-2, 3 or more), comorbidity (any comorbidity defined by Charlson index, no (ref)), body mass index (BMI<25 (ref), 25-<30, 30+ kg/m2), smoking (never (ref), past, current), physical activity (quartiles, Q1=ref).
FACT-B=Functional Assessment Cancer Therapy-Breast; FACT-G=Functional Assessment Cancer Therapy-General; TOI-PFB=Trial Outcome Index-Physical/Functional/Breast